Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinicopathologic and Molecular Analysis of the TFEB Fusion Variant Reveals New Members of TFEB Translocation Renal Cell Carcinomas (RCCs)
Qiuyuan Xia, Xiaotong Wang, Ru Fang, et al.
The American Journal of Surgical Pathology (2019) Vol. 44, Iss. 4, pp. 477-489
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
Kiril Trpkov, Ondřej Hes, Sean R. Williamson, et al.
Modern Pathology (2021) Vol. 34, Iss. 7, pp. 1392-1424
Open Access | Times Cited: 198
What’s new in the WHO 2022 classification of kidney tumours?
Reza Alaghehbandan, Farshid Siadat, Kiril Trpkov
Pathologica (2023), pp. 1-15
Open Access | Times Cited: 34
The WHO 2022 Classification of Renal Neoplasms (5th Edition): Salient Updates
Parth Goswami, Gyanendra Singh, Tarang Patel, et al.
Cureus (2024)
Open Access | Times Cited: 9
Translocation carcinomas of the kidney
Pedram Argani
Genes Chromosomes and Cancer (2021) Vol. 61, Iss. 5, pp. 219-227
Closed Access | Times Cited: 51
French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer
Pierre Bigot, Philippe Barthélémy, R. Boissier, et al.
Progrès en Urologie (2022) Vol. 32, Iss. 15, pp. 1195-1274
Closed Access | Times Cited: 34
Proteogenomic characterization of MiT family translocation renal cell carcinoma
Yuanyuan Qu, Xiaohui Wu, Aihetaimujiang Anwaier, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 30
TSC/MTOR-associated Eosinophilic Renal Tumors Exhibit a Heterogeneous Clinicopathologic Spectrum
Qiuyuan Xia, Xiaotong Wang, Ming Zhao, et al.
The American Journal of Surgical Pathology (2022) Vol. 46, Iss. 11, pp. 1562-1576
Closed Access | Times Cited: 28
A review of neoplasms with MITF/MiT family translocations.
Shuanzeng Wei, Joseph R. Testa, Pedram Argani
PubMed (2022) Vol. 37, Iss. 4, pp. 311-321
Closed Access | Times Cited: 24
Multifaceted activities of transcription factor EB in cancer onset and progression
Elena Astanina, Federico Bussolino, Gabriella Doronzo
Molecular Oncology (2020) Vol. 15, Iss. 2, pp. 327-346
Open Access | Times Cited: 36
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1
Anna Caliò, Shuko Harada, Matteo Brunelli, et al.
Modern Pathology (2020) Vol. 34, Iss. 4, pp. 842-850
Open Access | Times Cited: 35
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms
Anna Caliò, Stefano Marletta, Matteo Brunelli, et al.
Virchows Archiv (2022) Vol. 481, Iss. 6, pp. 877-891
Open Access | Times Cited: 21
Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations
Tongbing Chen, Yan Peng, Ting Lei, et al.
Pathology & Oncology Research (2023) Vol. 29
Open Access | Times Cited: 12
Recurrent Tuberous Sclerosis Complex/Mammalian Target of Rapamycin Mutations Define Primary Renal Hemangioblastoma as a Unique Entity Distinct From Its Central Nervous System Counterpart
Xiaotong Wang, Ru Fang, Huiying He, et al.
The American Journal of Surgical Pathology (2024) Vol. 48, Iss. 7, pp. 874-882
Closed Access | Times Cited: 4
TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background
Kristýna Pivovarčíková, Reza Alaghehbandan, Tomáš Vaněček, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 322-322
Open Access | Times Cited: 19
MiT/TFE Family Renal Cell Carcinoma
Jinglong Tang, Masaya Baba
Genes (2023) Vol. 14, Iss. 1, pp. 151-151
Open Access | Times Cited: 10
TFE3/TFEB Altered Renal Cell Carcinomas in End-Stage Renal Disease Setting: A Single Institution Clinicopathological Study of 4 Cases.
Andrea Mladenovic, Lara R. Harik, Kristin K. Deeb, et al.
Human Pathology (2025), pp. 105783-105783
Closed Access
Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistry
Rumeal D. Whaley, Daniel R. Sill, Burak Tekin, et al.
Human Pathology (2025), pp. 105797-105797
Closed Access
Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas
Shuko Harada, Anna Caliò, Karen M. Janowski, et al.
Modern Pathology (2021) Vol. 34, Iss. 11, pp. 2055-2063
Open Access | Times Cited: 22
Nuclear translocation of ASPL-TFE3 fusion protein creates favorable metabolism by mediating autophagy in translocation renal cell carcinoma
Ru Fang, Xiaotong Wang, Qiuyuan Xia, et al.
Oncogene (2021) Vol. 40, Iss. 18, pp. 3303-3317
Closed Access | Times Cited: 19
Novel TNC-PDGFD fusion in fibrosarcomatous dermatofibrosarcoma protuberans: a case report
Yuan Chen, Ying-zhou Shi, Xiaohe Feng, et al.
Diagnostic Pathology (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 18
Immunohistochemistry for the diagnosis of renal epithelial neoplasms
Mahmut Akgul, Sean R. Williamson
Seminars in Diagnostic Pathology (2021) Vol. 39, Iss. 1, pp. 1-16
Closed Access | Times Cited: 17
5mC and H3K9me3 of TRAF3IP2 promoter region accelerates the progression of translocation renal cell carcinoma
Lei Yang, Yi Chen, Ning Liu, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 12
French AFU Cancer Committee Guidelines – Update 2024–2026: Management of kidney cancer
P. Bigot, Romain Boissier, Z. Khene, et al.
Deleted Journal (2024) Vol. 34, Iss. 12, pp. 102735-102735
Open Access | Times Cited: 2
Uterine Tumor Resembling Ovarian Sex Cord Tumor With Aggressive Histologic Features Harboring a GREB1-NCOA2 Fusion: Case Report With a Brief Review
Xiaona Yin, Min Wang, Huiying He, et al.
International Journal of Gynecological Pathology (2022) Vol. 42, Iss. 1, pp. 54-62
Closed Access | Times Cited: 11
Identification of COL1A1/2 Mutations and Fusions With Noncoding RNA Genes in Bizarre Parosteal Osteochondromatous Proliferation (Nora Lesion)
Yu‐Chien Kao, Akihiko Yoshida, Tsung‐Han Hsieh, et al.
Modern Pathology (2023) Vol. 36, Iss. 2, pp. 100011-100011
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top